An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease. 2013

Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, United Kingdom.

Neurofibrillary tangles, one of the hallmarks of Alzheimer disease (AD), are composed of paired helical filaments of abnormally hyperphosphorylated tau. The accumulation of these proteinaceous aggregates in AD correlates with synaptic loss and severity of dementia. Identifying the kinases involved in the pathological phosphorylation of tau may identify novel targets for AD. We used an unbiased approach to study the effect of 352 human kinases on their ability to phosphorylate tau at epitopes associated with AD. The kinases were overexpressed together with the longest form of human tau in human neuroblastoma cells. Levels of total and phosphorylated tau (epitopes Ser(P)-202, Thr(P)-231, Ser(P)-235, and Ser(P)-396/404) were measured in cell lysates using AlphaScreen assays. GSK3α, GSK3β, and MAPK13 were found to be the most active tau kinases, phosphorylating tau at all four epitopes. We further dissected the effects of GSK3α and GSK3β using pharmacological and genetic tools in hTau primary cortical neurons. Pathway analysis of the kinases identified in the screen suggested mechanisms for regulation of total tau levels and tau phosphorylation; for example, kinases that affect total tau levels do so by inhibition or activation of translation. A network fishing approach with the kinase hits identified other key molecules putatively involved in tau phosphorylation pathways, including the G-protein signaling through the Ras family of GTPases (MAPK family) pathway. The findings identify novel tau kinases and novel pathways that may be relevant for AD and other tauopathies.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071679 Glycogen Synthase Kinase 3 beta A glycogen synthase kinase-3 type enzyme that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER. GSK-3beta,GSK3B Protein,GSK3beta,GSK 3beta
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau

Related Publications

Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
January 1996, Molecular and cellular biochemistry,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
January 2007, The European journal of neuroscience,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
July 1998, Neuroreport,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
May 2013, The Journal of biological chemistry,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
January 1993, Agents and actions. Supplements,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
March 2020, Nature reviews. Neurology,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
January 1986, Annals of the New York Academy of Sciences,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
February 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
September 2014, Annals of neurology,
Annalisa Cavallini, and Suzanne Brewerton, and Amanda Bell, and Samantha Sargent, and Sarah Glover, and Clare Hardy, and Roger Moore, and John Calley, and Devaki Ramachandran, and Michael Poidinger, and Eric Karran, and Peter Davies, and Michael Hutton, and Philip Szekeres, and Suchira Bose
November 1997, Biochemistry,
Copied contents to your clipboard!